Sunday, February 20, 2011

BIO BOARD OF DIRECTORS INDUCTS A NEW MEMBER

Mr. Beer Joins Emerging Companies Section Governing Board - Cambridge, MA, February 16, 2011 - Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat severe lipid disorders, announced the appointment of Chief Executive Officer Marc D. Beer to The Biotechnology Industry Organization's Board of Directors as a member of the Emerging Companies Section Governing Board. BIO is the world's largest biotechnology organization, providing advocacy, business development and communications services for more than 1,100 members worldwide. MYFEEDME

No comments:

Post a Comment

ShareThis

Become A Fan

Tweet